Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Salesh Balak B.A., BA, C.A., CA | Company Secretary & Corporate Advisor | 325.61k | -- | 1969 |
| Mr. Nicholas Bliesner | Head of Operations | -- | -- | -- |
| Mr. Luke Cossins B.Sc., M.B.A. | Head of Research & Development | -- | -- | -- |
| Ms. Ann Chew B.Com., CPA, CIA | Head of People Strategy & Culture | -- | -- | -- |
Universal Biosensors, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 80
Description
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.
Corporate Governance
Upcoming Events
January 29, 2025 at 10:59 AM UTC - February 3, 2025 at 12:00 PM UTC
Universal Biosensors, Inc. Earnings Date
Recent Events
May 28, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)